新興国の心血管インターベンション(装置及び技術)市場:ブラジル、ロシア、インド、中国、南アフリカ、韓国

◆英語タイトル:Interventional Cardiology (Devices & Technology) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
◆商品コード:AXIS41203
◆発行会社(リサーチ会社):Axis Research Mind
◆発行日:2014年11月
◆ページ数:623
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ブラジル、ロシア、インド、中国、アフリカ、韓国
◆販売価格オプション(消費税別)
Single User LicenseUSD3,100 ⇒換算¥322,400見積依頼/購入/質問フォーム
Enterprise-wide LicenseUSD4,700 ⇒換算¥488,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAxis Research Mind社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Axis Research Mind社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Global Market Watch:
BRICSS Interventional Cardiology Devices sector is projected to reach at US$3.3 billion by 2016. China accounts for highest percentage approximately 28% (2015) of global share while India follows next with nearly 25% (2018) of the market. Forecasts for Cardiac Catheters indicate a close 50%, while Arteriotomy Closure Devices accounts for nearly 6% of the market share. Predictions for BRICSS in Coronary Guidewires sector in which china accounts for nearly 29% of the market value and India is the fastest growing area at a CAGR of 14.3% for the analytical period of 2012-2018.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:
The report ‘Interventional Cardiology Devices – Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:

· Emerging Market Trends

· Advancements in the Technological Space

· Market Demand of The Segments (By-Region)

· Key Growth Areas and Market Size

· Region-Wise Demand Factor

· Key Competitors Edge

· Investment Strategies

The analysis primarily deals with by devices & technology. Further, the subdivided categories include:

Interventional Cardiology Devices – By Devices & Technology

1. Devices

A. Coronary Stents

a. Drug-Eluting Stents (DES)

b. Bare Metal Stents (BMS)

c. Absorbable Stents/Biodegradable Metallic Stent

d. Anti-Restenosis Devices

i. Bioactive Stent

ii. Radioactive Stent

iii. Drug Eluting Balloon (DEB) / Drug Coated Balloon (DCB)

B. Cardiac Catheters

a. Electrophysiology (EP) Catheters

b. PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloons Catheters

c. Intravascular Ultrasound (IVUS)

d. PTA (Percutaneous Transluminal Angioplasty) Balloons

e. Guiding Catheters

f. Angiography Catheters

g. Pulmonary Artery Catheters

h. Inflation Devices & Accessories

C. PTCA/Coronary Guidewires

D. Arteriotomy Closure Devices &

E. Introducer Sheaths& Other (Accessory Devices)

2. Technology

A. Fractional Flow Reserve (FFR)

B. Optical Coherence Tomography (OCT)

The period considered for the interventional cardiology devices market analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil, Russia, India, China, South Korea and South Africa).

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 182 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

【レポートの目次】

I. REPORT FOCUS

A. INTRODUCTION

CARDIOLOGY

OF CARDIAC CONDITIONS

A. BLOOD FLOW IN THE HEART

. HEART MALFUNCTION

TYPES OF CARDIAC ARREST

C. MYOCARDIUM

DISORDERS OF MYOCARDIUM

D. PERICARDIUM

E. HEART VALVES

DISORDERS OF HEART VALVES

F. CONGENITAL HEART DEFECT

TYPES OF CONGENITAL HEART DEFECT

G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)

H. HEART FAILURE

B. CARDIOVASCULAR DEVICES

DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT

TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME

TOOLS DEPLOYED IN CARDIOLOGY

DIAGNOSTIC TESTS AND PROCEDURES

CONCLUSION

C. INTERVENTIONAL CARDIOLOGY

A. INTERVENTIONAL DIAGNOSTICS AND ITS TECHNOLOGIES

I. INTRAVENOUS ULTRASOUND (IVUS)

II. OPTICAL COHERENCE TOMOGRAPHY (OCT)

III. FRACTIONAL FLOW RESERVE (FFR) – A BIG TECHNOLOGICAL BREAKTHROUGH

IMPLICATIONS OF FFR GROWTH – FALL IN USE OF GUIDEWIRES AND DES IN PATIENTS WITH MULTIVESSEL STENOSES

FFR HAS GREATER IMPACT ON THE GLOBAL MARKET IN THE LONG TERM

EMERGING RIVAL TECHNOLOGIES: CT-FFR AND IFR

THE RESULTS OF A CLINICAL TRIAL COMPARING IFR TO FFR

PERCUTANEOUS CORONARY INTERVENTION (PCI)

B. INTERVENTIONAL CARDIAC DEVICES

I. CORONARY STENTS

ADVANCES IN STENT TECHNOLOGY: EXPECTATIONS AND NEW DEVELOPMENTS

STENT SCAFFOLD STRUCTURE

CORONARY STENT COATING TYPES – IN BRIEF

TYPES OF STENT COATINGS, IN BRIEF:-

A. INORGANIC COATINGS

GOLD

SILICON CARBIDE

IRIDIUM OXIDE

CARBON

TITANIUM-NITRIDE-OXIDE

B. POLYMER COATINGS

NON-BIODEGRADABLE POLYMERS

BIODEGRADABLE POLYMERS

C. NON-POLYMER COATINGS/SURFACES:

MICROPOROUS SURFACES

MICROSTRUCTURED SURFACES

SLOTTED TUBULAR SURFACES

NANOPOROUS SURFACES

NPS

NANO-PATTERNED SURFACES

D. OTHER COATINGS/STRATEGIES

HEPARIN

HYALURONIC ACID (HA)

FIBRIN

ENDOTHELIAL CELLS (EC)

CONCLUSION

CARDIAC STENT USAGE IN THE US

PROCEDURES PERFORMED

PREFERRED STENT TYPE

STENT FACTORS AND THE IMPORTANCE OF VENDOR RELATIONSHIPS

A. DRUG-ELUTING STENTS (DES)

DIAGNOSTICS LIKELY TO CHANGE DES USAGE

INTRAVENOUS DIAGNOSTICS: THE FUTURE GATEKEEPER FOR STENT USAGE

DES: THE NEXT TARGET FOR MEDICAL SPENDING CUTS

DES AT THE FOREFRONT OF PRICE CUTS AND USAGE LIMITATION

ASIAN-BORN INNOVATION TO TARGET A DECLINING DES MARKET IN FUTURE

THE BEST STENTS AVAILABLE IN MARKET AND INNOVATIONS ARE ON THE WAY

GROWTH TREND OF ASIAN COMPANIES COMPARABLE TO US COMPANIES’ IN THE LATE 90’S

US AND JAPAN BREAKDOWN OF PCI CASES

GLOBAL DRUG-ELUTING STENT MARKET LIKELY TO DECLINE

NEXT GENERATION STENTS – BVS, SYNERGY, TCD-10023 AND BIOFREEDOM

FIRST-GENERATION STENTS

SECOND-GENERATION STENTS

THIRD-GENERATION STENTS

B. BARE METAL STENTS (BMS)

BARE-METAL AND DRUG-ELUTING STENTS MARKET

C. ABSORBABLE STENTS/BIODEGRADABLE METALLIC STENT

BIOABSORBABLE STENT SCAFFOLDS

SELF-EXPANDING STENT SCAFFOLDS

MICROMESH COVERED STENT

DEDICATED BIFURCATION STENTS

SPECULATION ON BIO-ABSORBABLE STENTS

D. ANTI-RESTENOSIS DEVICES

VASCULAST™ – DRUG ELUTING COATING

COVIDIEN COMMENCES PATIENT ENROLMENT IN ANTI-RESTENOSIS STUDY

DRUG ELUTING BALLOONS

CONCLUSION

NEW DIRECTIONS FOR STENT TECHNOLOGY

STRONG GROWTH EXPECTED FOR BIOABSORABLE STENTS IN EUROPE, UNITED STATES

BIOSENSORS, ABBOTT, ART EMERGE AS BIOABSORABLE STENT COMPETITORS

BIFURCATED STENTS TO ENTER THE U.S. MARKET, EUROPEAN MARKET SEES DOUBLE DIGIT GROWTH

II. CARDIAC CATHETERS

RISKS OF CARDIAC CATHETERIZATION

CLINICAL TRIALS

TYPES OF CARDIAC CATHETERS

A. ELECTROPHYSIOLOGY (EP) CATHETERS

DIAGNOSTIC ELECTROPHYSIOLOGY

CONVENTIONAL EP DIAGNOSTIC CATHETERS

ABLATION CATHETERS

THE HEART’S ELECTRICAL SYSTEM

SUPRAVENTRICULAR TACHYCARDIA (SVT)

ATRIAL FIBRILLATION (AF)

ATRIAL FLUTTER (AF)

VENTRICULAR TACHYCARDIA (VT)

A. RADIOFREQUENCY (RF) EP ABLATION CATHETERS

B. CRYOABLATION EP CATHETERS

C. LASER ABLATION SYSTEMS

D. NAVIGATIONAL ADVANCED MAPPING ACCESSORIES

E. MICROWAVE ABLATION

B. PTCA (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY) BALLOONS CATHETERS

1. PRE-DILATATION

2. POST-DILATATION

HISTORY OF PTCA BALLOONS

RECENT NEW BALLOON CATHETERS

MARKET DRIVERS FOR U.S. PTCA AND CUTTING BALLOON CATHETERS

PTCA AND CUTTING BALLOON CATHETERS MARKET

(i) CHANGES IN FDA POLICY

(ii) PRE-/POST-STENT DILATIONS

(iii) CALCIFIED PLAQUE BUSTING

PTCA BALLOONS AND GUIDEWIRES TO BE IMPACTED

A GREAT OPPORTUNITY FOR NEW COMERS WHILE THE GLOBAL MARKET IS DECLINING

COMPETITOR ANALYSIS

C. INTRAVASCULAR ULTRASOUND (IVUS)

ULTRASONOGRAPHY OF A CORONARY ARTERY

ADVANTAGES OF INTRAVASCULAR ULTRASOUND

USES

VALIDATING THE EFFICACY OF NEW TREATMENTS

WORLD MARKET WATCH

D. PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) BALLOONS

E. GUIDING CATHETERS

CONCLUSION

F. ANGIOGRAPHY CATHETERS

G. PULMONARY ARTERY CATHETERS

USES

TECHNICAL DEVELOPMENTS

THERMAL DILUTION

PHARMACOTHERAPY LUMENS

SVO2 MEASUREMENT

TECHNIQUES

a. ZERO REFERENCE

b. CALIBRATION

c. DYNAMIC TUNING

PROS:

CONS:

H. INFLATION DEVICES & ACCESSORIES

III. PTCA/CORONARY GUIDEWIRES

PURPOSE OF THE GUIDEWIRE

PROPERTIES OF AN IDEAL GUIDEWIRE

HISTORY OF PTCA GUIDEWIRE

GUIDEWIRE STRATEGIES FOR APPROACHING CTO

A) GUIDEWIRES FOR APPROACHING MICRO-CHANNELS

B) GUIDEWIRES FOR DRILLING STRATEGY

C) GUIDEWIRES FOR PENETRATING STRATEGY

D) GUIDEWIRES FOR RETROGRADE TECHNIQUE

PTCA DEVICES: AN EVEN MORE CHALLENGED MARKET THAN DES

IV. ARTERIOTOMY CLOSURE DEVICES

V. INTRODUCER SHEATHS

D. INTERVENTIONAL CARDIOLOGY – DEVICES – MARKET BRIEFING

CHINA

INDIA

BRAZIL

RUSSIA

SOUTH KOREA

SOUTH AFRICA

II. MARKET ANALYSIS

INTERVENTIONAL CARDIOLOGY (DEVICES & TECHNOLOGY) – BRICSS – INDUSTRY SNAPSHOT

A. INTERVENTIONAL CARDIAC DEVICES – SEGMENTATION

INTERVENTIONAL CARDIOLOGY – GLOBAL

INTERVENTIONAL CARDIOLOGY – DEVICES & TECHNOLOGY – GLOBAL

INTERVENTIONAL CARDIOLOGY – DEVICES – GLOBAL

INTERVENTIONAL CARDIOLOGY – BRICSS

INTERVENTIONAL CARDIOLOGY – DEVICES – BRICSS

INTERVENTIONAL CARDIOLOGY – BRICSS

INTERVENTIONAL CARDIOLOGY – BY DEVICE

A. CORONARY STENTS

CORONARY STENTS – BY TYPE

CORONARY STENTS – BRICSS – BY TYPE

DRUG-ELUTING STENTS (DES)

BARE METAL STENTS (BMS)

ABSORBABLE STENTS

ANTI-RESTENOSIS DEVICES

B. CARDIAC CATHETERS

CARDIAC CATHETERS – BY TYPE

CARDIAC CATHETERS - BRICSS - TYPES

ELECTROPHYSIOLOGY (EP) CATHETERS

PTCA (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY) BALLOONS CATHETERS

PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) BALLOON CATHETERS

GUIDING CATHETERS

ANGIOGRAPHY CATHETERS

PULMONARY ARTERY CATHETERS (PAC)

INTRAVASCULAR ULTRASOUND (IVUS)

INFLATION DEVICES & ACCESSORIES

C. PTCA/CORONARY GUIDEWIRES

D. ARTERIOTOMY CLOSURE DEVICES

E. INTRODUCER SHEATHS (IS) & OTHER

INTERVENTIONAL CARDIOLOGY - TECHNOLOGY – GLOBAL

INTERVENTIONAL CARDIOLOGY - BY TECHNOLOGY - BY TYPE

INTERVENTIONAL CARDIOLOGY - PCI PROCEDURES - GLOBAL

B. GROWTH RATE ANALYSIS

BRICSS INTERVENTIONAL CARDIAC DEVICES MARKET GROWTH RATES

BRICSS INTERVENTIONAL CARDIAC DEVICES - GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS

AN ENCOURAGING JAB FOR TORPID PERIODS

A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES

CARDIAC RHYTHM MANAGEMENT DEVICES

CRM IN EUROPE

CARDIAC DEFIBRILLATORS

RAPID GROWTH IN DEFIBRILLATOR SALES

CARDIAC PACEMAKER DEVICES

THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT)

CARDIAC MONITORING AND DIAGNOSTIC DEVICES

THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS

INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET

THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW

INTERVENTIONAL CARDIAC DEVICES

CORONARY STENTS

EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION

FFR IMPACT ON DES MARKET

MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET

CARDIAC CATHETERS

COMPETITIVE ANALYSIS

ELECTROPHYSIOLOGY CATHETERS (EP)

GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE

DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH

EP MAPPING

NEW AF ABLATION DEVICES SEEK APPROVAL

ATRIAL FIBRILLATION (AF)

INTRAVASCULAR ULTRASOUND (IVUS)

GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS

PERIPHERAL VASCULAR DEVICES

ARTERIOTOMY CLOSURE DEVICES

EMBOLIC PROTECTION DEVICES (EPD)

INFERIOR VENA CAVA (IVC) FILTERS

CONCLUSION

PERIPHERAL GUIDEWIRES

AV ACCESS THROMBECTOMY DEVICES

PROSTHETIC HEART VALVES

SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW

MARKET CHALLENGES

B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE

DRIVERS IN THE MEDICAL IMPLANT INDUSTRY

SIZE AND WEIGHT

POWER EFFICIENCY

PERFORMANCE SPECIFICATIONS

RISK MITIGATION AND RELIABILITY

EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE

CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY

IMPACT OF CVD IN EUROPE

IMPACT ON NEW YORK STATE

ECONOMIC IMPACT OF CVD IN NYS

HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION

IMPACT OF CVD ON ECONOMIC STABILITY

ECONOMIC COST OF CARDIOVASCULAR DISEASES

COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030

CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE

D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND

E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES

F. MARKET TRENDS

PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL

CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS

GE HEALTHCARE’S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS

GE’S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.

CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE

INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)

TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS

INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS

STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)

VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING

VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING

STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION

GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL

MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES

B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD

MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING

RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH

A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN

ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY

SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.

FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK’S NEW EVIA HF-T PACEMAKER.

AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL

SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS

USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS

MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN.

MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT

DRUG-ELUTING STENTS ARE SECURE

CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY

ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME

ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT

ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.

BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.

HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS

FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK

FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”

BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE

COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET

MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE

MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.

NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY—INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH

FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA

STUDY REVEALS THAT BAYER HEALTHCARE’S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.

USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS

SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011

TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY

CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL

SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)

EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.

ZOLL NOMINATED TO GLOBE 100 AGAIN

USCOM ENTERS EUROPEAN MARKETS

POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS

USCOM SECURES STRONG PRESENCE IN US AND CANADA

CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES

COVIDIEN INTRODUCES NEW GLOBAL PACKAGING

STENTYS’S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.

SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT

CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD

USCOM EYES EASTERN EUROPEAN MARKET

VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART

INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES

INFECTIONS FROM IMPLANTED CARDIAC DEVICES

TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION

HEART TRANSPLANTS SUBSTITUTED BY A PUMP

DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)

REMOTE MONITORING OF HEART FAILURE PATIENTS

EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES

OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION

IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH

OVER-THE-COUNTER APPARATUS

BOSTON SCIENTIFICS’ IMPLANTABLE DEFIBRILLATOR

CARDIAC SCIENCE’S NEW CARDIAC TREATMENT

THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION

CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD

LOCAL MEDICARE’S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY

A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION

A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC

LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA

INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS

BEST AND LATEST SELF-TEACHING HEART SOUNDS

REPLACING VALVE WITHOUT CARDIAC SUPPORT

U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT

AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES

NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA

MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS

G. KEY COMPANY PROFILES

NORTH AMERICA

EUROPE

ASIA-PACIFIC

REST OF WORLD

OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES

CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS

CARDIAC MEDICAL DEVICES – PATENTS

KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX

RESEARCH FOCUS

ABOUT AXIS RESEARCH MIND

DISCLAIMER

FEEDBACK

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[新興国の心血管インターベンション(装置及び技術)市場:ブラジル、ロシア、インド、中国、南アフリカ、韓国]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆